Researchers
Our research is structured into research themes, programs of work and teams. We are committed to collaboration and to work together.
Research theme leaders
BA (Education) PhD Candidate
Director of First Nations Strategy and Leadership; Head, First Nations Health and Equity Research
BSc PhD
Head, Chronic Diseases Research
OAM BSc (Hons) GradDipClinEpi PhD
BSc (Hons) PhD
Head, Brain and Behaviour Research
BSc (Hons) MSc PhD
Feilman Fellow; Head, Precision Health Research and Head, Computational Biology
BMedSci (hons), PhD
Shaping excellence
Rewarding excellence
Learn more about how The Kids rewards research excellence
Learn more about how The Kids rewards research excellenceResearch governance
We pride ourselves on conducting research to the highest standards possible
Find out more about research governanceCurrent career opportunities
Want to join our team and help make a difference to child health?
Learn more about Current career opportunitiesHelp shape our research
Find out how you can involve consumers and the community in your research
Help shape our researchReports & findings
Australian Group on Antimicrobial Resistance surveillance outcome programs - bloodstream infections and antimicrobial resistance patterns in Australian children and adolescents 2022 - 2023
Between January 2022 and December 2023, there were 1,827 bloodstream infection (BSI) isolates in 1,745 children and adolescents reported to the Australian Group on Antimicrobial Resistance (AGAR) surveillance outcome programs, with 40% of episodes in children aged < 12 months.
Rethinking a hybrid malaria chemoprevention delivery strategy for children in sub-perennial settings: a modelling study integrating age- and seasonally-targeted delivery
The World Health Organization recommends perennial malaria chemoprevention (PMC), generally using sulfadoxine-pyrimethamine (SP) to children at high risk of severe Plasmodium falciparum malaria. Currently, PMC is given up to age two in perennial transmission settings. However, no recommendation exists for perennial settings with seasonal variation in transmission intensity, recently categorized as 'sub-perennial'.
Rethinking a hybrid malaria chemoprevention delivery strategy for children in sub-perennial settings: a modelling study integrating age- and seasonally-targeted delivery
The World Health Organization recommends perennial malaria chemoprevention (PMC), generally using sulfadoxine-pyrimethamine (SP) to children at high risk of severe Plasmodium falciparum malaria. Currently, PMC is given up to age two in perennial transmission settings. However, no recommendation exists for perennial settings with seasonal variation in transmission intensity, recently categorized as 'sub-perennial'.
Neonatal and infant mortality after maternal influenza and pertussis vaccination: Probabilistically linked cohort study
Maternal influenza and pertussis vaccination is an important strategy to reduce morbidity and mortality in infants. Previous vaccine safety studies have mostly focused on the association between maternal vaccination and fetal death.